Shareholder Alert: Robbins LLP Informs Investors of Class Action Against AbbVie Inc. (ABBV)Business Wire • 04/08/22
ABBV EQUITY ALERT: Kessler Topaz Meltzer & Check, LLP Files Investor Securities Fraud Class Action Lawsuit against AbbVie, Inc. (ABBV)Business Wire • 04/08/22
Kessler Topaz Meltzer & Check, LLP Files Investor Securities Fraud Class Action Lawsuit Against AbbVie, Inc. (ABBV)PRNewsWire • 04/07/22
ABBVIE INC. (NYSE: ABBV) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against AbbVie Inc. (NYSE: ABBV)PRNewsWire • 04/07/22
ABBV Investor Alert: ROSEN, Global Investor Counsel, Encourages AbbVie Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - ABBVNewsfile Corp • 04/07/22
EQUITY NOTICE: ROSEN, A TOP RANKED LAW FIRM, Encourages AbbVie Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – ABBVBusiness Wire • 04/06/22
Allergan, an AbbVie Company, Announces Positive Topline Phase 3 Results Evaluating Investigational Twice-Daily Administration of VUITY™ (pilocarpine HCI ophthalmic solution) 1.25% in Adults with Age-Related Blurry Near Vision (Presbyopia)PRNewsWire • 04/05/22
West Virginia Says J&J, Teva, AbbVie Caused 'Tsunami' Of Opioid Addiction: ReutersBenzinga • 04/04/22
Resorts World Las Vegas Secures First-of-its-Kind Agreement With Allergan AestheticsBusiness Wire • 04/04/22
AbbVie to Showcase Breadth of Neuroscience Portfolio and Pipeline at American Academy of Neurology (AAN) 2022 Annual MeetingPRNewsWire • 03/29/22